Global Point-Of-Care Diagnostics Market is Projected to Grow at a CAGR of 10.4% from 2019 to 2024HomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global Point-Of-Care Diagnostics Market is Projected to Grow at a CAGR of 10.4% from 2019 to 2024GlobeNewswireJanuary 2, 2020ReblogShareTweetShareDublin, Jan. 02, 2020 (GLOBE NEWSWIRE) -- The "Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.The global point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR of 10.4%.Factors such as the high prevalence of infectious diseases in developing countries, increasing incidence of target conditions, and increasing inclination toward home healthcare across the globe are driving the market for point-of-care diagnostics. However, product recalls, a lack of alignment with test results obtained from laboratories, stringent & time-consuming approval policies, and a reluctance to change existing diagnostic practices are expected to restrain market growth. The glucose monitoring products segment is expected to command the largest share of the POC diagnostics market in 2019.Based on product, the point-of-care diagnostics market is segmented into glucose monitoring, infectious disease testing, cardiometabolic monitoring, coagulation monitoring, hematology testing, urinalysis testing, cholesterol testing, drugs-of-abuse testing, tumor/cancer markers, pregnancy & fertility testing, fecal occult testing, and other POC products. The glucose monitoring products segment is expected to command the largest share of the market in 2019. The increasing number of POC glucose monitoring devices, coupled with the growing prevalence of diabetes, is expected to drive the growth of the POC diagnostics market for glucose monitoring products in the coming years.The microfluidics segment is expected to register the highest growth rate in the POC diagnostics market, by platform, during the forecast period.On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The microfluidics segment is expected to register the highest growth rate during the forecast period. Technological advancements and increasing initiatives by market players for developing novel microfluidics-based POC products are propelling the growth of the microfluidics market. The Asia Pacific market is expected to register the highest CAGR during the forecast period.The point-of-care diagnostics market, by region, is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to register the highest growth rate during the forecast period, due to the growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures in this region.This report studies the point-of-care diagnostics market based on product, platform, mode of purchase, end user, and region. The report also studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to the five key regions and their respective countries.Key Topics Covered: Premium Insights POC Diagnostics Market OverviewGeographic Analysis: POC Diagnostics MarketPOC Diagnostics Market, By ProductPOC Diagnostics Market, By Prescription ModeGeographic Snapshot of the POC Diagnostics MarketMarket Overview Point-Of-Care Diagnostics Market, By Product Glucose Monitoring ProductsCardiometabolic Monitoring ProductsInfectious Disease Testing ProductsCoagulation Monitoring ProductsPregnancy & Fertility Testing ProductsTumor/Cancer Marker Testing ProductUrinalysis Testing ProductsCholesterol Testing ProductsDrugs-Of-Abuse Testing ProductsFecal Occult Testing ProductsOther POC ProductsPoint-Of-Care Diagnostics Market, By Platform Lateral Flow AssaysDipsticksMicrofluidicsMolecular DiagnosticsImmunoassaysPoint-Of-Care Diagnostics Market, By Mode of Purchase Prescription-Based ProductsGrowing Prevalence of Lifestyle Diseases and Favorable Reimbursement Have Driven Market GrowthOTC ProductsRising Focus on Home Care is Expected to Boost Demand for OTC Testing in the Coming YearsPoint-Of-Care Diagnostics Market, By End User Professional Diagnostic CentersHospitals/Critical Care CentersHome Care SettingsResearch LaboratoriesOther End UsersPoint-Of-Care Diagnostics Market, By Region Competitive Landscape Ranking of Players, 2018Competitive ScenarioProduct Launches, Enhancements, and ApprovalsAgreements, Partnerships, and CollaborationsAcquisitionsVendor Dive OverviewVendor Inclusion CriteriaVendor DiveCompany Profiles Abbott LaboratoriesBecton, Dickinson, and CompanyChembio DiagnosticsDanaher CorporationJohnson & JohnsonRoche Diagnostics Siemens Healthineers GroupEKF DiagnosticsQuidelTrinity BiotechAccubiotechInstrumentation LaboratoryNova BiomedicalPTS Diagnostics Sekisui DiagnosticsFor more information about this report visit https://www.researchandmarkets.com/r/11cnl3About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Story continuesReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextHow investors are using ‘alternative’ data to track China’s recovery from coronaviruMarketWatchBank of Canada to stay put for now, but 2020 rate cut in play: Reuters pollReutersWorld stocks set for worst week since 2008 as virus fears grip marketsReutersOil-rich Alberta sees lower budget deficit in 2020-21, bets on recovery in crude pricesReutersRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceMost romantic destinations in North America ranked: The Points GuyYahoo Finance Video